Your browser doesn't support javascript.
loading
Dieta e medicamentos no tratamento da hiperuricemia em pacientes hipertensos / Diet and medication in the treatment of hyperuricemia in hypertensive patients
Peixoto, Maria do Rosário Gondim; Monego, Estelamaris Tronco; Jardim, Paulo César B. Veiga; Carvalho, Magna Maria; Sousa, Ana Luiza Lima; Oliveira, Jonivan Siqueira de; Balestra Neto, Otavio.
Affiliation
  • Peixoto, Maria do Rosário Gondim; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Monego, Estelamaris Tronco; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Jardim, Paulo César B. Veiga; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Carvalho, Magna Maria; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Sousa, Ana Luiza Lima; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Oliveira, Jonivan Siqueira de; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
  • Balestra Neto, Otavio; Universidade Federal de Goiás. Faculdades de Medicina Enfermagem e Nutriçäo. Goiânia. BR
Arq. bras. cardiol ; Arq. bras. cardiol;76(6): 463-472, June 2001. ilus, tab
Article in Pt, En | LILACS | ID: lil-286364
Responsible library: BR1.1
ABSTRACT

OBJECTIVE:

To evaluate the effects of diet and medication, either isolated or associated, on serum levels of uric acid in patients with hyperuricemia.

METHODS:

We studied patients from the Hypertension Unit of the University of Goias who had hyperuricemia (men > or = 8.5mg/dL and women > or = 7.5mg/dL). We divided the patients into three groups G1 (low purine diet), G2 (low purine diet + medication), and G3 (medication only). Patients received allopurinol, 150mg/day titrated up to 300mg/dL when necessary. Patients were evaluated with regards to their lifestyles (diet, smoking, physical, activity, alcohol consumption), uric acid, blood pressure, use of medication, body mass index, cholesterol, and triglyceride. Follow-up took place in weeks 0 (M1), 6 (M2), 12 (M3) during the intervention and in week 36(M4) after the study was completed.

RESULTS:

Fifty-five patients participated in the study, 31 women, mean age 54.4 + or - 10.6 years, body mass index 28.6 + or - 3.9kg/m². A similar reduction (p<0.001) in uric acid levels occurred in the three intervention groups. In week 36 (M4), after 24 weeks without intervention, a tendency toward elevation of uricemia was noted in G2 and G3, and a continuous drop in uricemia was noted in G1. No significant modifications were observed in the other variables analyzed.

CONCLUSION:

Considering the cost x benefit relationship, a diet low in purine should be the 1st therapeutic option for controlling hyperuricemia in patients with similar characteristic to the ones presented in this study
Subject(s)
Full text: 1 Index: LILACS Main subject: Purines / Uric Acid / Allopurinol / Diet / Hypertension Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En / Pt Journal: Arq. bras. cardiol Journal subject: CARDIOLOGIA Year: 2001 Type: Article
Full text: 1 Index: LILACS Main subject: Purines / Uric Acid / Allopurinol / Diet / Hypertension Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En / Pt Journal: Arq. bras. cardiol Journal subject: CARDIOLOGIA Year: 2001 Type: Article